
Home » NEWS FROM MEDIVIR'S ONGOING R&D DAY
NEWS FROM MEDIVIR'S ONGOING R&D DAY
Medivir is presenting an R&D update this afternoon on oral herpes project Lipsovir (ME 609) and the company's protease-based projects on Hepatitis C, osteoporosis and COPD (Chronic Obstructive Pulmonary Disease). A short summary will also be
given on the status of the spin out process for the company's HIV projects, Medivir
HIV Franchise AB.
Genetic
Engineering News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
30Nov
-
05Dec
-
07Dec
-
13Dec
-
14Apr